14 research outputs found
A MultiCenter analysis of factors associated with hearing outcome for 2,735 adults with cochlear implants
While the majority of cochlear implant recipients benefit from the device, it remains difficult to estimate the degree of benefit for a
specific patient prior to implantation. Using data from 2,735 cochlear-implant recipients from across three clinics, the largest retrospective study of cochlear-implant outcomes to date, we investigate the association between 21 preoperative factors and speech
recognition approximately one year after implantation and explore the consistency of their effects across the three constituent datasets. We provide evidence of 17 statistically significant associations, in either univariate or multivariate analysis, including confirmation
of associations for several predictive factors, which have only been examined in prior smaller studies. Despite the large sample size, a
multivariate analysis shows that the variance explained by our models remains modest across the datasets (R2 = 0.12–0.21). Finally,
we report a novel statistical interaction indicating that the duration of deafness in the implanted ear has a stronger impact on hearing
outcome when considered relative to a candidate’s age. Our multicenter study highlights several real-world complexities that impact
the clinical translation of predictive factors for cochlear implantation outcome. We suggest several directions to overcome these
challenges and further improve our ability to model patient outcomes with increased accuracy.The collection of the VUMC dataset was supported by a research project grant no. NIH NIDCD R01 DC13117 (principal investigator: Gifford).http://journals.sagepub.com/home/tiadm2022Speech-Language Pathology and Audiolog
Predictive models for cochlear implant outcomes : performance, generalizability, and the impact of cohort size
While cochlear implants have helped hundreds of thousands of individuals, it remains difficult to predict the extent to which
an individual’s hearing will benefit from implantation. Several publications indicate that machine learning may improve predictive accuracy of cochlear implant outcomes compared to classical statistical methods. However, existing studies are limited in
terms of model validation and evaluating factors like sample size on predictive performance. We conduct a thorough examination of machine learning approaches to predict word recognition scores (WRS) measured approximately 12 months after
implantation in adults with post-lingual hearing loss. This is the largest retrospective study of cochlear implant outcomes to
date, evaluating 2,489 cochlear implant recipients from three clinics. We demonstrate that while machine learning models
significantly outperform linear models in prediction of WRS, their overall accuracy remains limited (mean absolute error:
17.9-21.8). The models are robust across clinical cohorts, with predictive error increasing by at most 16% when evaluated
on a clinic excluded from the training set. We show that predictive improvement is unlikely to be improved by increasing
sample size alone, with doubling of sample size estimated to only increasing performance by 3% on the combined dataset.
Finally, we demonstrate how the current models could support clinical decision making, highlighting that subsets of individuals
can be identified that have a 94% chance of improving WRS by at least 10% points after implantation, which is likely to be
clinically meaningful. We discuss several implications of this analysis, focusing on the need to improve and standardize data
collection.http://journals.sagepub.com/home/tiadm2022Speech-Language Pathology and Audiolog
Finishing the euchromatic sequence of the human genome
The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead
Using ILD or ITD Cues for Sound Source Localization and Speech Understanding in a Complex Listening Environment by Listeners With Bilateral and With Hearing-Preservation Cochlear Implants
Reimplantation with a conventional length electrode following residual hearing loss in four hybrid implant recipients
The Benefits of Combining Acoustic and Electric Stimulation for the Recognition of Speech, Voice and Melodies
Recommended from our members
Unilateral cochlear implants for severe, profound, or moderate sloping to profound bilateral sensorineural hearing loss : a systematic review and consensus statements
IMPORTANCE Cochlear implants are a treatment option for individuals with severe, profound, or moderate sloping to profound bilateral sensorineural hearing loss (SNHL) who receive little or no benefit from hearing aids; however, cochlear implantation in adults is still not routine.
OBJECTIVE To develop consensus statements regarding the use of unilateral cochlear implants in adults with severe, profound, or moderate sloping to profound bilateral SNHL.
DESIGN, SETTING, AND PARTICIPANTS This study was a modified Delphi consensus process that was informed by a systematic review of the literature and clinical expertise. Searches were conducted in the following databases: (1) MEDLINE In-Process & Other Non-Indexed Citations and Ovid MEDLINE, (2) Embase, and (3) the Cochrane Library. Consensus statements on cochlear implantation were developed using the evidence identified. This consensus process was relevant for the use of unilateral cochlear implantation in adults with severe, profound, or moderate sloping to profound bilateral SNHL. The literature searches were conducted on July 18, 2018, and the 3-step Delphi consensus method took place over the subsequent 9-month period up to March 30, 2019.
MAIN OUTCOMES AND MEASURES A Delphi consensus panel of 30 international specialists voted on consensus statements about cochlear implantation, informed by an SR of the literature and clinical expertise. This vote resulted in 20 evidence-based consensus statements that are in line with clinical experience. A modified 3-step Delphi consensus method was used to vote on and refine the consensus statements. This method consisted of 2 rounds of email questionnaires and a face-to-face meeting of panel members at the final round. All consensus statements were reviewed, discussed, and finalized at the face-to-face meeting.
RESULTS In total, 6492 articles were identified in the searches of the electronic databases. After removal of duplicate articles, 74 articles fulfilled all of the inclusion criteria and were used to create the 20 evidence-based consensus statements. These 20 consensus statements on the use of unilateral cochlear implantation in adults with SNHL were relevant to the following 7 key areas of interest: level of awareness of cochlear implantation (1 consensus statement); best practice clinical pathway from diagnosis to surgery (3 consensus statements); best practice guidelines for surgery (2 consensus statements); clinical effectiveness of cochlear implantation (4 consensus statements); factors associated with postimplantation outcomes (4 consensus statements); association between hearing loss and depression, cognition, and dementia (5 consensus statements); and cost implications of cochlear implantation (1 consensus statement).
CONCLUSIONS AND RELEVANCE These consensus statements represent the first step toward the development of international guidelines on best practices for cochlear implantation in adults with SNHL. Further research to develop consensus statements for unilateral cochlear implantation in children, bilateral cochlear implantation, combined electric-acoustic stimulation, unilateral cochlear implantation for single-sided deafness, and asymmetrical hearing loss in children and adults may be beneficial for optimizing hearing and quality of life for these patients